90 related articles for article (PubMed ID: 22277388)
21. [Frontotemporal Lobar Degeneration: A Historical Overview of the Concept].
Kawakatsu S; Kobayashi R; Sakamoto K; Otani K
Brain Nerve; 2020 Jun; 72(6):561-573. PubMed ID: 32507755
[TBL] [Abstract][Full Text] [Related]
22. [History and classification of frontotemporal lobar degeneration].
Okamoto K
Brain Nerve; 2009 Nov; 61(11):1203-8. PubMed ID: 19938676
[TBL] [Abstract][Full Text] [Related]
23. [Pathomechanisms and clinical aspects of frontotemporal lobar degeneration].
Bürger K; Arzberger T; Stephan J; Levin J; Edbauer D
Nervenarzt; 2017 Feb; 88(2):163-172. PubMed ID: 27999880
[TBL] [Abstract][Full Text] [Related]
24. [Neuropathology of frontotemporal lobar degeneration with ubiquitinated inclusions].
Yoshida M
Brain Nerve; 2009 Nov; 61(11):1308-18. PubMed ID: 19938688
[TBL] [Abstract][Full Text] [Related]
25. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
[TBL] [Abstract][Full Text] [Related]
26. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
[TBL] [Abstract][Full Text] [Related]
27. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions.
Neumann M; Kwong LK; Truax AC; Vanmassenhove B; Kretzschmar HA; Van Deerlin VM; Clark CM; Grossman M; Miller BL; Trojanowski JQ; Lee VM
J Neuropathol Exp Neurol; 2007 Mar; 66(3):177-83. PubMed ID: 17356379
[TBL] [Abstract][Full Text] [Related]
28. Frontotemporal Lobar Degeneration.
Premi E; Padovani A; Borroni B
Adv Exp Med Biol; 2012; 724():114-27. PubMed ID: 22411238
[TBL] [Abstract][Full Text] [Related]
29. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
30. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies.
Sampathu DM; Neumann M; Kwong LK; Chou TT; Micsenyi M; Truax A; Bruce J; Grossman M; Trojanowski JQ; Lee VM
Am J Pathol; 2006 Oct; 169(4):1343-52. PubMed ID: 17003490
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions.
Yokota O; Tsuchiya K; Arai T; Yagishita S; Matsubara O; Mochizuki A; Tamaoka A; Kawamura M; Yoshida H; Terada S; Ishizu H; Kuroda S; Akiyama H
Acta Neuropathol; 2009 Apr; 117(4):429-44. PubMed ID: 19194716
[TBL] [Abstract][Full Text] [Related]
32. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions.
Mackenzie IR; Foti D; Woulfe J; Hurwitz TA
Brain; 2008 May; 131(Pt 5):1282-93. PubMed ID: 18362096
[TBL] [Abstract][Full Text] [Related]
33. Expanding the Phenotype of Frontotemporal Lobar Degeneration With FUS-Positive Pathology (FTLD-FUS).
Chornenka K; Hirsch-Reinshagen V; Perez-Rosendahl M; Feldman H; Segal-Gidan F; Vinters HV; Mackenzie IR
J Neuropathol Exp Neurol; 2020 Jul; 79(7):809-812. PubMed ID: 32483606
[TBL] [Abstract][Full Text] [Related]
34. Transportin1: a marker of FTLD-FUS.
Brelstaff J; Lashley T; Holton JL; Lees AJ; Rossor MN; Bandopadhyay R; Revesz T
Acta Neuropathol; 2011 Nov; 122(5):591-600. PubMed ID: 21847626
[TBL] [Abstract][Full Text] [Related]
35. [FTLD-U and Pick disease without Pick bodies--a clinical and pathological review].
Ikeda K
Brain Nerve; 2009 Nov; 61(11):1328-36. PubMed ID: 19938690
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathological features of sporadic frontotemporal lobar degeneration with TDP-43-positive inclusions].
Yokota O
Rinsho Shinkeigaku; 2010 Nov; 50(11):1018-21. PubMed ID: 21921551
[TBL] [Abstract][Full Text] [Related]
37. [Neuropathology of frontotemporal dementia].
Murayama S
Rinsho Shinkeigaku; 2008 Nov; 48(11):998. PubMed ID: 19198143
[TBL] [Abstract][Full Text] [Related]
38. Als and Ftd: Insights into the disease mechanisms and therapeutic targets.
Liscic RM
Eur J Pharmacol; 2017 Dec; 817():2-6. PubMed ID: 29031901
[TBL] [Abstract][Full Text] [Related]
39. Topographic distribution of brain iron deposition and small cerebrovascular lesions in amyotrophic lateral sclerosis and in frontotemporal lobar degeneration: a post-mortem 7.0-tesla magnetic resonance imaging study with neuropathological correlates.
De Reuck J; Devos D; Moreau C; Auger F; Durieux N; Deramecourt V; Pasquier F; Maurage CA; Cordonnier C; Leys D; Bordet R
Acta Neurol Belg; 2017 Dec; 117(4):873-878. PubMed ID: 28988390
[TBL] [Abstract][Full Text] [Related]
40. Atypical FTLD-FUS associated with ALS-TDP: a case report.
Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H
Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
